ad4-h5-vtn
Vaccineexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2009 (NCT01006798)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ad4-h5-vtn
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01806909 | Phase 1 | Feb 7, 2013 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT01443936 | Phase 1 | Sep 12, 2011 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT01006798 | Phase 1 | Oct 1, 2009 | PaxVax, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 2 | 2 | 1 | 2011 |
| PaxVax, Inc. | For profit | 1 | 1 | 1 | 2009 |
2 organizations
Page 1 / 1